Gilead Sciences Closes Durham, North Carolina R&D Office
06/24/2010
"This comes after a lengthy review," Flood said. "We will be consolidating our R&D activities in our Foster City, [California] headquarters."
The Durham closure leaves Gilead with no presence in North Carolina.
Gilead is a bioscience company that conducts anti-viral research and development. The Durham office conducted hepatitis B and C clinical research.
Project Announcements
Hims & Hers Health Expands New Albany, Ohio, Operations
12/28/2025
Poly6 Technologies Expands Eastlake, Ohio, Operations
12/26/2025
Ohio Lumex Expands Solon, Ohio, Operations
12/26/2025
Calgon Carbon Corporation Expands Pittsburgh, Pennsylvania, Operations
12/25/2025
Cascades Expands Eau Claire, Wisconsin, Operations
12/25/2025
P.C. Campana Plans Vicksburg, Mississippi, Production Operations
12/25/2025
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
Lead with Facts, Land the Deal
Q3 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025
-
America’s Aerospace Reboot
Q3 2025
-
The Permit Puzzle and the Path to Groundbreaking
Q3 2025